Skip to main content

Table 1 Clinical details at diagnosis and during follow-up in patients with PIBD-related CRC

From: Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series

Patient No.

Patient 1

Patient 2

Patient 3

Patient 4

Sex

M

M

M

M

Age at first IBD diagnosis (years)

12

11

5

16

Year of first diagnosis

2000

2010

2001

2018

Type of IBD

CD

UC

VEOIBD

CD

Genetic findings

NA

NA

Negative

NA

Disease location (Paris classification)

L3

E4

L3

L4

Perianal diseases

Fistula

Skin tag

(−)

(−)

Luminal complications

Luminal stricture

Bowel obstruction

(−)

(−)

Luminal narrowing

Bowel obstruction

 Thiopurine (years)

9.43

2.05

2.48

0.42

 TNF inhibitor (years)

(−)

3.44

(−)

(−)

 Methotrexate (years)

(−)

0.33

(−)

(−)

 Other biologicals (years)

(−)

0.71 (Golimumab)

(−)

(−)

Surgery before cancer diagnosis

(−)

(−)

(−)

(−)

 Age at cancer diagnosis (years)

24

20

15

17

 Location

Transverse colon

Sigmoid colon

Ascending, sigmoid colon

Sigmoid colon

 Histological type

Mucinous carcinoma

Adenocarcinoma

Adenocarcinoma

Signet ring carcinoma

 Stage according to AJCC 8th

pT3N0M0

pT1N0M0

pT3N0M0

pT4aN2bM1

 Disease duration before cancer diagnosis (years)

11.96

8.9

9.93

0.44

 Last follow-up (year)

2020 (Ongoing)

2020 (Ongoing)

2020 (Ongoing)

2019 (Expired)

  1. IBD inflammatory bowel disease, TNF tumor necrosis factor, AJCC American Joint Committee on Cancer, NA not applicable